Enantioselective metabolism of (R)- and (S)-4-hydroxy-2-nonenal in rat

被引:10
作者
Guéraud, F [1 ]
Crouzet, F [1 ]
Alary, J [1 ]
Rao, D [1 ]
Debrauwer, L [1 ]
Laurent, F [1 ]
Cravedi, JP [1 ]
机构
[1] INRA, UMR Xenobiot 1089, F-31931 Toulouse 9, France
关键词
lipid peroxidation; 4-hydroxy-2-nonenal; stereoselectivity; aldo-keto reductase; glutathione conjugation;
D O I
10.1002/biof.5520240111
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
4-Hydroxy-2-nonenal (HNE) is an endogenous product of lipid peroxidation, which is believed to play a biological role in the pathogenesis of various diseases. HNE is formed as a racemic mixture of ( R)- and (S)-enantiomers. These enantiomers differ in their biological properties. The aim of this study was to investigate separately the in vivo metabolism of the two HNE enantiomers in male rats after intravenous administration of the corresponding radiolabeled compounds and to compare the results with those obtained with the racemic mixture. Although the difference in the excretion rates was not statistically significant, the HPLC profiles of urinary metabolites showed qualitative and quantitative differences between the two enantiomers. The level of 3-mercapturic acid-1,4-dihydroxynonane, which is considered as the major urinary metabolite of HNE, was significantly lower in the case of ( S)- HNE injected rats. In vitro studies using rat liver cytosolic incubations and HNE-glutathione conjugate as substrate were performed to clarify the intermediate pathways involved in their metabolism. Large differences were obtained in the reduction and retro-Michael conversion steps of the metabolism between the conjugates originating from the two enantiomers.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 18 条
[1]   1,4-dihydroxynonene mercapturic acid, the major end metabolite of exogenous 4-hydroxy-2-nonenal, is a physiological component of rat and human urine [J].
Alary, J ;
Debrauwer, L ;
Fernandez, Y ;
Cravedi, JP ;
Rao, D ;
Bories, G .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (02) :130-135
[2]   Identification of intermediate pathways of 4-hydroxynonenal metabolism in the rat [J].
Alary, J ;
Fernandez, Y ;
Debrauwer, L ;
Perdu, E ;
Guéraud, F .
CHEMICAL RESEARCH IN TOXICOLOGY, 2003, 16 (03) :320-327
[3]   Identification of novel urinary metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in rats [J].
Alary, J ;
Debrauwer, L ;
Fernandez, Y ;
Paris, A ;
Cravedi, JP ;
Dolo, L ;
Rao, D ;
Bories, G .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (11) :1368-1376
[4]  
Alary Jacques, 2003, Molecular Aspects of Medicine, V24, P177, DOI 10.1016/S0098-2997(03)00012-8
[5]   ENZYMATIC RESOLUTION OF (R)-(E)-4-HYDROXYALK-2-ENALS AND (S)-(E)-4-HYDROXYALK-2-ENALS RELATED TO LIPID-PEROXIDATION [J].
ALLEVI, P ;
ANASTASIA, M ;
CAJONE, F ;
CIUFFREDA, P ;
SANVITO, AM .
JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (18) :5000-5002
[6]   SYNTHESIS OF 4-HYDROXY[4-H-3]-2(E)-NONEN-1-AL-DIETHYLACETAL [J].
BRAVAIS, F ;
RAO, D ;
ALARY, J ;
RAO, RC ;
DEBRAUWER, L ;
BORIES, G .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1995, 36 (05) :471-477
[7]   4-HYDROXYNON-2-ENAL, A CYTOTOXIC LIPID-PEROXIDATION PRODUCT, AND ITS C-5-ANALOG 4-HYDROXYPENT-2-ENAL - ENANTIOSELECTIVE SYNTHESIS AND STEREOANALYSIS [J].
BRINGMANN, G ;
GASSEN, M ;
LARDY, R .
TETRAHEDRON, 1994, 50 (34) :10245-10252
[8]  
deZwart LL, 1996, XENOBIOTICA, V26, P1087
[9]   4-hydroxynonenal and cell signalling [J].
Dianzani, MU .
FREE RADICAL RESEARCH, 1998, 28 (06) :553-560
[10]   ACTION OF ALDEHYDES ON NORMAL AND MALIGNANT CELLS .3. SYNTHESIS OF HOMOLOGUES OF 4-HYDROXY-2-ALKENALS .2. [J].
ESTERBAU.H ;
WEGER, W .
MONATSHEFTE FUR CHEMIE, 1967, 98 (05) :1994-&